Screener
ALX Oncology Holdings Inc. ALXO Q4 2025 Annual earnings
Reported February 27, 2026 · Before market open
EPS-$0.42Miss by $0.04
EPS estimate-$0.38
Next report
Nov 6, 2026 (in 2 months)EPS estimate-$0.15
Versus estimates
Diluted EPS
FAQ
- When did ALX Oncology Holdings Inc. report Q4 2025 earnings?
- ALX Oncology Holdings Inc. (ALXO) reported Q4 2025 earnings on February 27, 2026 before market open.
- What were ALX Oncology Holdings Inc.'s Q4 2025 revenue and EPS?
- ALX Oncology Holdings Inc. reported eps of $-0.42 for Q4 2025.
- Did ALX Oncology Holdings Inc. beat estimates in Q4 2025?
- EPS missed the consensus estimate of $-0.38 by $0.04.
- How did ALX Oncology Holdings Inc.'s Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 23.6% from $-0.55.
- Where can I find ALX Oncology Holdings Inc.'s Q4 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-26-079342) and the 10-K periodic report (0001193125-26-098454) directly on SEC EDGAR. The filing index links above go to sec.gov.
